MXCT vs NWS · rev $38.6M vs rev $9.03B
MaxCyte Inc (MXCT) versus NWS (NWS) — a side-by-side from cached financials, not a winner call.
MaxCyte Inc (MXCT) is a medical devices company listed on NASDAQ.
NWS (NWS) common stock.
Latest reported MXCT revenue for 2024-12-31 was $38.6M. Net income was -$41.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. MXCT currently screens at market cap $124.3M.
Latest reported NWS revenue for 2026-06-30 was $9.03B. Net income was $573.0M. Revenue was up 6.8% from 2025-06-30 to 2026-06-30. NWS currently screens at market cap $0.
MXCT currently screens at market cap $124.3M. NWS currently screens at market cap $0.
Not investment advice. Open the MXCT and NWS stock pages for the full models.
Not investment advice.